Skip to main content

Octagon Capital Advisors LP

Position in OCUL — Ocular Therapeutix, Inc

CIK 1839435 NEW YORK, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,376,500
-$6,444,602 QoQ
Shares Held
2,075,000
-34.5% QoQ
Ownership
0.945%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#15
of 257 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Octagon Capital Advisors LP holds $1,046,707,283 across 25 Biotechnology names. OCUL ranks #13 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,376,500 2,075,000
2026-03-31 $26,821,102 3,166,600
2025-12-31 $31,850,504 2,623,600
2025-09-30 $30,674,560 2,624,000
2025-06-30 $22,504,000 2,425,000
2025-03-31 $17,775,250 2,425,000
2024-12-31 $20,709,500 2,425,000
2024-09-30 $21,097,500 2,425,000
2024-06-30 $16,587,000 2,425,000
2024-03-31 $22,067,500 2,425,000